New diabetes clinical trial: Observational Study: Glycemic Control & CV Outcomes Among Patients With T2DM Newly Initiating GLP1-RAs vs Basal Insulin

Published on: July 03, 2019 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: GLP-1 receptor agonist;   Drug: Basal insulin
Sponsor:   Brigham and Women's Hospital
Active, not recruiting